Page 84 - Read Online

tumors. J Neurooncol 2014;118:225-38. author reply 3-4.
41. Qaddoumi I, Sane M, Li S, Kocak M, Pai-Panandiker A, Harreld 58. Brunn A, Montesinos-Rongen M, Strack A, Reifenberger G, Mawrin
J, Klimo P, Wright K, Broniscer A, Gajjar A. Diagnostic utility and C, Schaller C, Deckert M. Expression pattern and cellular sources
correlation of tumor markers in the serum and cerebrospinal fluid of chemokines in primary central nervous system lymphoma. Acta
of children with intracranial germ cell tumors. Childs Nerv Syst Neuropathol 2007;114:271-6.
2012;28:1017-24. 59. Sasagawa Y, Akai T, Tachibana O, Iizuka H. Diagnostic value of
42. Nishizaki T, Kajiwara K, Adachi N, Tsuha M, Nakayama H, Ohshita interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma
N, Ikeda N, Ito H, Suzuki M. Detection of craniospinal dissemination of the central nervous system. J Neurooncol 2015;121:177-83.
of intracranial germ cell tumours based on serum and cerebrospinal 60. Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan
fluid levels of tumour markers. J Clin Neurosci 2001;8:27-30. S, Blaney SM, Phillips P, Packer R, Gordish-Dressman H, Rood BR.
43. Watanabe S, Aihara Y, Kikuno A, Sato T, Komoda T, Kubo O, Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2
Amano K, Okada Y, Koyamaishi Y. A highly sensitive and specific synthase as a putative biomarker for pediatric medulloblastoma: A
chemiluminescent enzyme immunoassay for placental alkaline pediatric brain tumor consortium study. Proteomics 2011;11:935-43.
phosphatase in the cerebrospinal fluid of patients with intracranial 61. Saso L, Leone MG, Sorrentino C, Giacomelli S, Silvestrini B, Grima
germinomas. Pediatr Neurosurg 2012;48:141-5. J, Li JC, Samy E, Mruk D, Cheng CY. Quantification of prostaglandin
44. Miyanohara O, Takeshima H, Kaji M, Hirano H, Sawamura Y, D synthetase in cerebrospinal fluid: a potential marker for brain
Kochi M, Kuratsu J. Diagnostic significance of soluble c-kit in the tumor. Biochem Mol Biol Int 1998;46:643-56.
cerebrospinal fluid of patients with germ cell tumors. J Neurosurg 62. Desiderio C, D’Angelo L, Rossetti DV, Iavarone F, Giardina B,
2002;97:177-83. Castagnola M, Massimi L, Tamburrini G, Di Rocco C. Cerebrospinal
45. Ilhan-Mutlu A, Wagner L, Wohrer A, Jungwirth S, Marosi C, Fischer fluid top-down proteomics evidenced the potential biomarker role of
P, Preusser M. Blood alterations preceding clinical manifestation of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain
glioblastoma. Cancer Invest 2012;30:625-9. tumors. Proteomics 2012;12:2158-66.
46. Khwaja FW, Reed MS, Olson JJ, Schmotzer BJ, Gillespie GY, 63. Figarella-Branger D, Dubois C, Chavin P, De Victor B, Gentet JC,
Guha A, Groves MD, Kesari S, Pohl J, Van Meir EG. Proteomic Rougon G. Correlation between polysialic-neural cell adhesion
identification of biomarkers in the cerebrospinal fluid (CSF) of meolecule levels in CSF and medulloblastoma outcomes. J Clin
astrocytoma patients. J Proteome Res 2007;6:559-70. Oncol 1996;14:2066-72.
47. Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir EG. Attractin 64. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated
is elevated in the cerebrospinal fluid of patients with malignant serum bone sialoprotein and osteopontin in colon, breast, prostate,
astrocytoma and mediates glioma cell migration. Clin Cancer Res and lung cancer. Clin Cancer Res 2001;7:4060-6.
2006;12:6331-6. 65. Kao CL, Chiou SH, Ho DM, Chen YJ, Liu RS, Lo CW, Tsai FT, Lin
48. Sampath P, Weaver CE, Sungarian A, Cortez S, Alderson L, Stopa CH, Ku HH, Yu SM, Wong TT. Elevation of plasma and cerebrospinal
EG. Cerebrospinal fluid (vascular endothelial growth factor) and fluid osteopontin levels in patients with atypical teratoid/rhabdoid
serologic (recoverin) tumor markers for malignant glioma. Cancer tumor. Am J Clin Pathol 2005;123:297-304.
Control 2004;11:174-80. 66. de Bont JM, van Doorn J, Reddingius RE, Graat GH, Passier
49. Schuhmann MU, Zucht HD, Nassimi R, Heine G, Schneekloth MM, den Boer ML, Pieters R. Various components of the insulin-
CG, Stuerenburg HJ, Selle H. Peptide screening of cerebrospinal like growth factor system in tumor tissue, cerebrospinal fluid and
fluid in patients with glioblastoma multiforme. Eur J Surg Oncol peripheral blood of pediatric medulloblastoma and ependymoma
2010;36:201-7. patients. Int J Cancer 2008;123:594-600.
50. Ohnishi M, Matsumoto T, Nagashio R, Kageyama T, Utsuki S, 67. de Bont JM, Vanderstichele H, Reddingius RE, Pieters R, van Gool
Oka H, Okayasu I, Sato Y. Proteomics of tumor-specific proteins SW. Increased total-Tau levels in cerebrospinal fluid of pediatric
in cerebrospinal fluid of patients with astrocytoma: usefulness of hydrocephalus and brain tumor patients. Eur J Paediatr Neurol
gelsolin protein. Pathol Int 2009;59:797-803. 2008;12:334-41.
51. Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, 68. Albulescu R, Codrici E, Popescu ID, Mihai S, Necula LG, Petrescu
Hwang E, Kilburn L, Packer RJ, Nazarian J. Insights into pediatric D, Teodoru M, Tanase CP. Cytokine patterns in brain tumour
diffuse intrinsic pontine glioma through proteomic analysis of progression. Mediators Inflamm 2013;2013:979748.
cerebrospinal fluid. Neuro Oncol 2012;14:547-60. 69. Zhao G, Yang Y, Su X. Determination of S-100 beta protein in
52. Galati D, Di Noto R, Del Vecchio L. Diagnostic strategies to cerebrospinal fluid of patients with metastatic carcinoma to central
investigate cerebrospinal fluid involvement in haematological nervous system. Zhonghua Nei Ke Za Zhi 2000;39:732-4. (in Chinese)
malignancies. Leuk Res 2013;37:231-7. 70. Wang P, Piao Y, Zhang X, Li W, Hao X. The concentration of CYFRA
53. Huttner A. Overview of primary brain tumors: pathologic 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators
classification, epidemiology, molecular biology, and prognostic for diagnosis of meningeal carcinomatosis of lung cancer. Cancer
markers. Hematol Oncol Clin North Am 2012;26:715-32. Biomark 2013;13:123-30.
54. Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous 71. Bakri Y, al-Hawashim N, Berkowitz R. CSF/serum beta-hCG ratio
meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol in patients with brain metastases of gestational trophoblastic tumor. J
Int 2013;4:S265-88. Reprod Med 2000;45:94-6.
55. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, 72. de Bont JM, den Boer ML, Reddingius RE, Jansen J, Passier M,
Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, van Schaik RH, Kros JM, Sillevis Smitt PA, Luider TH, Pieters
Schulman H, Rubenstein JL. Protein biomarker identification in the R. Identification of apolipoprotein A-II in cerebrospinal fluid of
CSF of patients with CNS lymphoma. J Clin Oncol 2008;26:96-105. pediatric brain tumor patients by protein expression profiling. Clin
56. Kuusisto ME, Haapasaari KM, Remes AM, Bloigu R, Karihtala P, Chem 2006;52:1501-9.
Turpeenniemi-Hujanen T, Kuittinen O. Antithrombin III is probably 73. Groves MD, Hess KR, Puduvalli VK, Colman H, Conrad CA, Gilbert
not a suitable biomarker for diagnosis of primary central nervous MR, Weinberg J, Cristofanilli M, Yung WK, Liu TJ. Biomarkers
system lymphoma. Ann Hematol 2015;94:1167-74. of disease: cerebrospinal fluid vascular endothelial growth factor
57. Zetterberg H, Andreasson U, Blennow K. CSF antithrombin III and (VEGF) and stromal cell derived factor (SDF)-1 levels in patients
disruption of the blood-brain barrier. J Clin Oncol 2009;27:2302-3; with neoplastic meningitis (NM) due to breast cancer, lung cancer

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 18, 2016 ¦ 185